top of page

Hello.
Welcome to BioFocus.
Explore the latest updates from the life science industry.

Popular Content.
PHARMA
LEO Pharma strengthens psoriasis portfolio in China with NMPA approval of Enstilar®
NMPA approval of Enstilar® marks a key expansion for LEO Pharma in China, bringing a widely used topical psoriasis treatment to an estimated 6.5 million patients amid growing demand for innovative dermatology care.
Featured Articles.
Latest News.
27th April, 2026
01.
LEO Pharma strengthens psoriasis portfolio in China with NMPA approval of Enstilar®
NMPA approval of Enstilar® marks a key expansion for LEO Pharma in China, bringing a widely used topical psoriasis treatment to an estimated 6.5 million patients amid growing demand for innovative dermatology care.

14th April, 2026
03.
Andelyn Biosciences and Evolyra Therapeutics Join Forces to Advance Gene Therapies for Limb-Girdle Muscular Dystrophy
A new CDMO partnership aims to bring clinical-grade AAV gene therapies to patients with LGMD types 2C and 2D, with an IND filing targeted for the second half of 2026

bottom of page















